Elicio Therapeutics (ELTX) Current Leases (2021 - 2026)
Elicio Therapeutics posted quarterly Current Leases of $1.0 million for Q1 2026, up 12.53% year-on-year from $926000.0 in Q1 2025, and up 3.07% on a QoQ basis from $1.0 million in Q4 2025.
Elicio Therapeutics (ELTX) has 6 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 12.53% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 12.53% YoY), and the FY2025 full-year result was $1.0 million, up 12.21% from the prior year.
- Current Leases for Q1 2026 stood at $1.0 million, up from $1.0 million in the prior quarter.
- Across five years, Current Leases topped out at $1.0 million in Q1 2026 and bottomed at $60000.0 in Q1 2022.
- The 5-year median for Current Leases is $910000.0 (2023), against an average of $780411.8.
- The widest annual swing landed in 2022, when Current Leases slumped 92.68%; it then surged 1488.71% in 2023.
- A 5-year view of Current Leases shows it stood at $692000.0 in 2022, then jumped by 31.5% to $910000.0 in 2023, then retreated by 0.99% to $901000.0 in 2024, then advanced by 12.21% to $1.0 million in 2025, then gained by 3.07% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Dec 31, 2024 | 901,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 854,000.00 |
| Mar 31, 2024 | 881,000.00 |
| Dec 31, 2023 | 910,000.00 |
| Sep 30, 2023 | 938,000.00 |
| Jun 30, 2023 | 985,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 692,000.00 |
| Sep 30, 2022 | 968,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 894,000.00 |
| Sep 30, 2021 | 870,000.00 |
| Jun 30, 2021 | 847,000.00 |
| Mar 31, 2021 | 780,000.00 |